BioPharmX   Report issue

For profit Phase 4
Founded: Menlo Park CA United States (2011)
Status: Acquired by Timber Pharmaceuticals LLC (2020) → now Leo Pharma (2023)

Organization Overview

First Clinical Trial
2016
NCT02676336
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

BioPharmX, Inc. | Sponsor (BioPharmX)

Active Ingredients

Drugs in Phase 4 Trials (1)

minocycline (minocin) (6 trials)

Drugs in Other Trials (1)

iodine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 2)

Rosacea (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 2